Hsbc Holdings PLC Lantheus Holdings, Inc. Transaction History

Hsbc Holdings PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$82.41 - $99.65 $2.03 Million - $2.46 Million	24,681 Added 980.96%	27,197 $2.28 Million
Q1 2023 May 15, 2023	SELL	$47.76 - $82.86 $2.31 Million - $4.01 Million	-48,338 Reduced 95.05%	2,516 $207,000
Q4 2022 Feb 14, 2023	BUY	$48.76 - $77.67 $1.84 Million - $2.94 Million	37,791 Added 289.3%	50,854 $2.59 Million
Q3 2022 Nov 14, 2022	SELL	$61.42 - $86.29 $318,094 - $446,895	-5,179 Reduced 28.39%	13,063 $935,000
Q2 2022 Aug 11, 2022	SELL	$55.54 - $72.65 $90,696 - $118,637	-1,633 Reduced 8.22%	18,242 $1.2 Million
Q1 2022 May 16, 2022	BUY	$24.28 - $56.64 $187,830 - $438,167	7,736 Added 63.73%	19,875 $1.13 Million
Q4 2021 Feb 11, 2022	BUY	$22.54 - $30.44 $76,996 - $103,983	3,416 Added 39.16%	12,139 $350,000
Q3 2021 Nov 12, 2021	SELL	$24.23 - $28.59 $22,679 - $26,760	-936 Reduced 9.69%	8,723 $224,000
Q2 2021 Aug 13, 2021	BUY	$19.51 - $27.64 $188,447 - $266,974	9,659 New	9,659 $266,000

542

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.29B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.